Diplin M
Composition:
Diplin™ M 500 Tablet: Each film coated tablet contains Linagliptin INN 2.5 mg & Metformin Hydrochloride BP 500 mg.
Indications:
Diplin™ M 500 is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide combination product indicated as
an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when
treatment with both Linagliptin and Metformin is appropriate.
Dose & Administration:
The maximum recommended dose is Linagliptin 2.5 mg/Metformin Hydrochloride 1000 mg twice daily Or as directed by the physician.
Diplin
Composition:
Diplin™ 5 Tablet: Each film coated tablet contains Linagliptin INN 5 mg
Indication:
Diplin™ is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.
Dose & Administration:
The recommended dose of Diplin™ is 5 mg once daily. No dosage adjustment is required for hepatic or kidney impaired patients. Or as directed by the physician.
Desatrol
COMPOSITION :
Desatrol™Tablet : Each film coated tablet contains Desloratadine BP 5 mg.
Desatrol™Syrup : Each 5 ml syrup contains Desloratadine BP 2.5 mg.
INDICATION :
Allergic Rhinitis: Desatrol™ is indicated for the relief of the nasal and nonnasal symptoms of allergic rhinitis (seasonal and perennial).
Chronic idiopathic Urticaria: Desatrol™ is indicated for the symptomatic relief of pruritus, reduction in the number of hives and size of hives, in patients with chronic idiopathic urticaria.
DOSE AND ADMINISTRATION :
Tablet : In adults and children 12 years of age and over, the recommended dose is 5 mg once daily.
In patients with liver or renal impairment, a starting dose of one 5 mg tablet every other day is recommended.
Syrup : Children 2-5 years of age : 2.5 ml once daily, 6-11 years of age : 5 ml once daily. Adults and children 12 years of age and over : 10 ml once daily. It may be administered with or without food. Or as directed by the physician.
Dextac
Composition
Dextac™30 Capsule:Each capsule contains Dexlansoprazole INN 30 mg as enteric coated pellets.
Dextac™60 Capsule:Each capsule contains Dexlansoprazole INN 60 mg as enteric coated pellets.
Indication
• Healing of Erosive Esophagitis: Dextac™ (Dexlansoprazole) is indicated for healing of all grades of Erosive Esophagitis (EE) for up to 8 weeks.
• Maintenance of Healed Erosive Esophagitis: Dextac™ (Dexlansoprazole) is indicated to maintain healing of EE and relief of heartburn for up to 6 months.
• Symptomatic Non-Erosive Gastroesophageal Reflux Disease: Dextac™ (Dexlansoprazole) is indicated for the treatment of heartburn associated with symptomatic Non-Erosive Gastroesophageal Reflux Disease (GERD) for upto 4 weeks.
Dose & Administration
Important Administration Information
• Dextac™ (Dexlansoprazole) can be taken without regard to food or the timing of food.
• Dextac™ (Dexlansoprazole) should be swallowed whole.
Alternatively, Dextac™ (Dexlansoprazole) capsules can be administered as follows:
- Open capsule.
- Sprinkle intact granules on one table spoon.
- Swallow immediately. Granules should not be chewed.
Missed Dose: If a capsule is missed at its usual time, it should be taken as soon as possible. But
if it is too close to the time of the next dose, only the prescribed dose should be taken at the
appointed time. A double dose should not be taken. or as directed by the physicians.
Duracef
Composition:
Duracef™ 200 Capsule: Each capsule contains Cefixime Trihydrate BP equivalent to Cefixime 200 mg.
Duracef™ 400 Capsule: Each capsule contains Cefixime Trihydrate BP equivalent to Cefixime 400 mg.
Duracef™ 200 Tablet: Each film coated tablet contains Cefixime Trihydrate BP equivalent to Cefixime 200 mg.
Duracef™ DS PFS (50 ml): Each 5 ml reconstituted suspension contains Cefixime Trihydrate BP equivalent to Cefixime 200 mg.
Duracef™ PFS (50 ml): Each 5 ml reconstituted suspension contains Cefixime Trihydrate BP equivalent to Cefixime 100 mg.
Duracef™ PFS (30 ml): Each 5 ml reconstituted suspension contains Cefixime Trihydrate BP equivalent to Cefixime 100 mg.
Duracef™ Paediatric Drops (21 ml): Each ml reconstituted suspension contains Cefixime Trihydrate BP equivalent to Cefixime 25 mg.
Duracef™ Max PFS (10 ml): Each 5 ml reconstituted suspension contains Cefixime Trihydrate BP equivalent to Cefixime 500 mg.
Duracef™ Max PFS (20 ml): Each 5 ml reconstituted suspension contains Cefixime Trihydrate BP equivalent to Cefixime 500 mg.
Indications:
Otitis media- caused by Streptococcus pneumoniae (including Penicillinase resistant strains), Streptococcus pyogenes, Haemophilus influenzae (including beta-lactamase producing strains), Moraxella catarrhalis (including beta-lactamase producing strains). Pharyngitis/Tonsillitis- caused by Streptococcus pyogenes. Uncomplicated Urinary Tract infection- Caused by E. coli, Proteus mirabilis. Uncomplicated Gonorrhoea- Caused by N. gonorrhoeae (including Penicillinase & nonPenicillinase resistant strains).
Dosage and Administration:
Adults: The recommended dose is given as a single dose of 400 mg or 200 mg twice daily for 7-14 days according to the severity of infections. Uncomplicated Gonorrhoea. 400 mg single dose.
Children:
> 6 months: 8 mg /kg/ day in 1-2 divided doses
6 months-1 year: 75 mg daily
1-4 years: 100 mg daily
5-10 years: 200 mg daily
> 10 years: As same as adult dose or as directed by the physician
